Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy
Crossref DOI link: https://doi.org/10.1007/s40273-014-0249-4
Published Online: 2015-01-11
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Akpo, Essè Ifèbi Hervé
Cerri, Karin
Kleintjens, Joris
License valid from 2015-01-11